Mar 22 2024
Establishing the PTT-based UFH Therapeutic Range
A March 22 entry from Robyn Coleman, Senior Scientist, Coagulation, Haematology, Sullivan Nicolaides Pathology, Queensland, Australia: Dear George, I am seeking some direction on APTT therapeutic ranges for UFH. We are facing a change to our APTT reagent. The cohort of patients we would have traditionally used to validate UFH therapeutic range (TR) for APTT, […]
read more